ODDB.org: Open Drug Database

Home - 00485 - 26 - 008

Influvac, Injektionssuspension - 10 Fertigspritze(n) à 0.5 ml

Swissmedic Key	00485008	Registration Holder	Mylan Pharma GmbH
Name	Influvac, Injektionssuspension	Date of registration	24.06.1988
		Introduction of Sequence	06.09.2013
ATC-Classification	Influenza, Inactivated, Split Virus Or Surface Antigen (J07BB02)	Revision date
WHO	WHO-DDD	Valid until	30.06.2022
Index Therapeuticus (BSV)	08.08.	Show package size	10 Fertigspritze(n) à 0.5 ml
Index Therapeuticus (Swissmedic)	08.08.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680004850080	Medication Code	Impfstoffe
Pharmacode		Disponibility

Composition

haemagglutininum influenzae A (H1N1) 15 µg et neuraminidasum inactivatum (Virus-Stamm A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-181), haemagglutininum influenzae A (H3N2) 15 µg et neuraminidasum inactivatum (Virus-Stamm A/Victoria/361/2011 (H3N2)-like: reassortant virus NYMC X-223A derived from A/Texas/50/2012), haemagglutininum influenzae B 15 µg et neuraminidasum inactivatum (Virus-Stamm B/Massachusetts/2/2012-like: reassortant virus NYMC BX-51B), kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: ovalbuminum max. 0.1 µg, saccharum et formaldehydum et cetrimidum et polysorbatum 80 et gentamicinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml.

Packungsbestandteile

Galenic Form	Injection suspension

Source

Data was imported : 22.01.2014 Swissmedic Registration : 00485 Sequence : 26 Product name : Influvac, Injektionssuspension Registration owner: : Abbott AG Product group : Index Therapeuticus (BSV) : 08.08. Medication Code : Impfstoffe Date of registration : 24.06.1988 Valid until : 30.06.2017 Package number : 008 Show package size : 10 x 0.5 ml Commercial Form/Unit : Fertigspritze(n) Swissmedic categorie. : B Active Agents : haemagglutininum influenzae A (H1N1), neuraminidasum inactivatum (Virus-Stamm A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-181), haemagglutininum influenzae A (H3N2), haemagglutininum influenzae B Composition : haemagglutininum influenzae A (H1N1) 15 µg et neuraminidasum inactivatum (Virus-Stamm A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-181), haemagglutininum influenzae A (H3N2) 15 µg et neuraminidasum inactivatum (Virus-Stamm A/Victoria/361/2011 (H3N2)-like: reassortant virus NYMC X-223A derived from A/Texas/50/2012), haemagglutininum influenzae B 15 µg et neuraminidasum inactivatum (Virus-Stamm B/Massachusetts/2/2012-like: reassortant virus NYMC BX-51B), kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: ovalbuminum max. 0.1 µg, saccharum et formaldehydum et cetrimidum et polysorbatum 80 et gentamicinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml.

2025	©ywesee GmbH